ARTICLE | Clinical News
Immunomedics regulatory update
September 11, 1995 7:00 AM UTC
The FDA's Oncologic Drugs Advisory Committee (ODAC) will review the Morris Plains, N.J., company's CEA-Scan colorectal cancer imaging agent on Oct. 17. ...
The FDA's Oncologic Drugs Advisory Committee (ODAC) will review the Morris Plains, N.J., company's CEA-Scan colorectal cancer imaging agent on Oct. 17. ...